Exploring the therapeutic space around NAD+
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
NAD+ is a central metabolite in the cell. Changes in NAD+ abundance and the activity of NAD+-dependent enzymes, such as the sirtuins, are at the core of metabolic/mitochondrial diseases, such as obesity and diabetes, and of cancer and neurodegeneration. Here, we discuss how maintaining or raising NAD+ levels can improve metabolism and prevent age-related functional decline and associated disease, and how basic scientific discoveries in the NAD+ signaling pathway are being translated to the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“, obesity, type 2 diabetes) and neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s; Lin and Beal, 2006; Houtkooper et al., 2010b; Patti and Corvera, 2010).”
BackgroundResveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057 · cited 4×
“…is confined to 207Exploring the therapeutic space around NAD+ • Houtkooper and Auwerx and NR, improve mitochondrial function in mice and correct the metabolic disturbances instigated by a high-fat diet regimen (Baur et al., 2006; Lagouge et al., 2006; Yoshino et al., 2011; Cantó et al., 2012).”
BackgroundInfluentialSelf-citationSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796 · cited 1×
“This initial excitement is now toned down, as SIRT1 overexpression or resveratrol treatment by themselves may not always be sufficient to extend lifespan in a major fashion (Tissenbaum and Guarente, 2001; Howitz et al., 2003; Bass et al., 2007; Burnett et al., 2011).”
BackgroundTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510 · cited 2×
“, 2000), and the identification of sirtuins as NAD-dependent enzymes (Imai et al., 2000).”
BackgroundAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · cited 1×
“…to activate 50% of the receptor; 250 nmol/L) resveratrol, often described as a red wine compound, activates the energy sensor AMP-activated protein kinase (AMPK; Baur et al., 2006; Cantó et al., 2009), which in turn stimulates NAD+ (re)synthesis (Fulco et al., 2008; Cantó et al., 2009).”
BackgroundSelf-citationMetabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130 · cited 2×
“2 A; Lin et al., 2005).”
BackgroundSirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008 · cited 7×
“Although the G protein–coupled receptor GPR109A was linked to the effects of niacin (Tunaru et al., 2003), an increase in NAD+ could also contribute, especially considering the central role of sirtuin enzymes in lipid metabolism (Schug and Li, 2011; Houtkooper et al., 2012).”
BackgroundSelf-citationLin, S.-J., Defossez, P.-A., & Guarente, L. (2000) · Science · doi:10.1126/science.289.5487.2126 · Cited by 1,775 · cited 2×
“The key discoveries that led to this increased interest in NAD+ metabolism were the finding that yeast Sir2p was required for the lifespan extension brought about by caloric restriction (Lin et al., 2000), and the identification of sirtuins as NAD+-dependent enzymes (Imai et al., 2000).”
BackgroundSIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation
Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., Grueter, C. A., Harris, C., Biddinger, S., Ilkayeva, O. R., et al. (2010) · Nature · doi:10.1038/nature08778 · Cited by 1,687
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320
Self-citationCantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238 · cited 10×
“SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation.”
BackgroundSelf-citationCantó, C., Jiang, L. Q., Deshmukh, A. S., Mataki, C., Coste, A., Lagouge, M., Zierath, J. R., & Auwerx, J. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.006 · Cited by 921 · cited 1×
“During energy crises such as caloric restriction, fasting, and exercise, NAD+ levels rise, concomitant with sirtuin activation (Chen et al., 2008; Cantó et al., 2010), while energy overload, such as seen with a high-fat diet, reduces the NAD+/NADH ratio (Kim et al., 2011).”
BackgroundSelf-citationThe secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899
Self-citationPARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation
Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R. H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.004 · Cited by 837 · cited 7×
“Although PARPs and cyclic ADP-ribose synthases play a crucial role in NAD+ homeostasis, their function by itself is less relevant for our story, which is why we will not discuss them in detail and refer the reader to a recent review (Houtkooper et al., 2010a).”
BackgroundSelf-citationStressing the role of FoxO proteins in lifespan and disease
van der Horst, A., & Burgering, B. M. T. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2190 · Cited by 759
Bieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750
Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila
Burnett, C., Valentini, S., Cabreiro, F., Goss, M., Somogyvári, M., Piper, M. D., Hoddinott, M., Sutphin, G. L., Leko, V., McElwee, J. J., et al. (2011) · Nature · doi:10.1038/nature10296 · Cited by 624 · cited 1×
“This initial excitement is now toned down, as SIRT1 overexpression or resveratrol treatment by themselves may not always be sufficient to extend lifespan in a major fashion (Tissenbaum and Guarente, 2001; Howitz et al., 2003; Bass et al., 2007; Burnett et al., 2011).”
BackgroundSirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer
Herranz, D., Muñoz-Martin, M., Cañamero, M., Mulero, F., Martinez-Pastor, B., Fernandez-Capetillo, O., & Serrano, M. (2010) · Nature Communications · doi:10.1038/ncomms1001 · Cited by 612 · cited 1×
“SIRT1 overexpressing transgenic mice are protected against age-related development of diabetes, and have lower incidence of carcinomas and sarcomas, even though they do not live longer (Herranz et al., 2010), suggesting that Sirt1 regulates healthy aging rather than lifespan itself.”
BackgroundTissue-specific regulation of SIRT1 by calorie restriction
Chen, D., Bruno, J., Easlon, E., Lin, S.-J., Cheng, H.-L., Alt, F. W., & Guarente, L. (2008) · Genes & Development · doi:10.1101/gad.1650608 · Cited by 567
The role of mitochondria in the pathogenesis of type 2 diabetes
Patti, M.-E., & Corvera, S. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0027 · Cited by 551
Mitochondria—A Nexus for Aging, Calorie Restriction, and Sirtuins?
Guarente, L. (2008) · Cell · doi:10.1016/j.cell.2008.01.007 · Cited by 513
The new life of a centenarian: signalling functions of NAD(P)
Berger, F. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.01.007 · Cited by 489
Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?
Cantó, C., & Auwerx, J. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003905 · Cited by 433
Self-citationMetabolomic Analysis of Livers and Serum from High-Fat Diet Induced Obese Mice
Kim, H.-J., Kim, J. H., Noh, S., Hur, H. J., Sung, M. J., Hwang, J.-T., Park, J. H., Yang, H. J., Kim, M.-S., Kwon, D. Y., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr100892r · Cited by 376 · cited 2×
“During energy crises such as caloric restriction, fasting, and exercise, NAD+ levels rise, concomitant with sirtuin activation (Chen et al., 2008; Cantó et al., 2010), while energy overload, such as seen with a high-fat diet, reduces the NAD+/NADH ratio (Kim et al., 2011).”
BackgroundMetabolic networks of longevity
Houtkooper, R. H., Williams, R. W., & Auwerx, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.029 · Cited by 217
Fernandez-Marcos, P. J., Jeninga, E. H., Canto, C., Harach, T., de Boer, V. C. J., Andreux, P., Moullan, N., Pirinen, E., Yamamoto, H., Houten, S. M., et al. (2012) · Scientific Reports · doi:10.1038/srep00425 · Cited by 137 · cited 1×
“2 A; Houtkooper et al., 2012), although its real physiological role in metabolic control is still debated (Hirschey et al., 2010; Fernandez-Marcos et al., 2012).”
BackgroundSelf-citationSIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity
Rutanen, J., Yaluri, N., Modi, S., Pihlajamäki, J., Vänttinen, M., Itkonen, P., Kainulainen, S., Yamamoto, H., Lagouge, M., Sinclair, D. A., et al. (2010) · Diabetes · doi:10.2337/db09-1191 · Cited by 104 · cited 1×
“In support of this hypothesis, high Sirt1 mRNA expression in adipose tissue of nondiabetic offspring of type 2 diabetic patients corresponds to increased energy expenditure and insulin sensitivity (Rutanen et al., 2010).”
BackgroundSelf-citation
Cited by
Mouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210
“, 2010b), we hypothesized that increasing NAD levels may be sufficient to increase mitochondrial activity and extend lifespan (Houtkooper and Auwerx, 2012).”
BackgroundSelf-citationSpermidine in health and disease
Madeo, F., Eisenberg, T., Pietrocola, F., & Kroemer, G. (2018) · Science · doi:10.1126/science.aan2788 · Cited by 1,154
Yun, J., & Finkel, T. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.011 · Cited by 626
“Although it remains uncertain to what degree enzymatic activity is normally regulated by cofactor availability, there is accumulating evidence that under various stresses, availability of these intermediates shapes biological outcomes (Dölle et al., 2013; Houtkooper and Auwerx, 2012).”
BackgroundNAD + metabolism: Bioenergetics, signaling and manipulation for therapy
Yang, Y., & Sauve, A. A. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.06.014 · Cited by 497
Zhu, X.-H., Lu, M., Lee, B.-Y., Ugurbil, K., & Chen, W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417921112 · Cited by 468
Metadata
- Authors
- Houtkooper, R. H., & Auwerx, J.
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2012-10-15
- Volume
- 199
- Issue
- 2
- Pages
- 205-209
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2111760164
- Cited by
- 109
- References
- 28
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.